Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion
Open accessThe DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a decisive element for the transcriptional regulation of many genes induced under low oxygen conditions. Under normal oxygen conditions, HIF-1alpha, the active subunit of HIF-1, is hydroxylated on proline residues by specific HIF prolyl-hydroxylases, leading to ubiquitination and degradation by the proteasome. In hypoxia, hydroxylation and ubiquitination are blocked and HIF-1alpha accumulates in cells. Recent studies have shown that in normal oxygen conditions G-protein-coupled receptor agonists, including angiotensin (Ang) II and thrombin, potently induce and activate HIF-1 in vascular smooth muscle cells. The current study identifies HIF-1alpha protein stabilization as a key mechanism for HIF-1 induction by Ang II. We show that hydroxylation on proline 402 is altered by Ang II, decreasing pVHL binding to HIF-1alpha and allowing HIF-1alpha protein to escape subsequent ubiquitination and degradation mechanisms. We show that HIF-1alpha stability is mediated through the Ang II-mediated generation of hydrogen peroxide and a subsequent decrease in ascorbate levels, leading to decreased HIF prolyl-hydroxylase activity and HIF-1alpha stabilization. These findings identify novel and intricate signaling mechanisms involved in HIF-1 complex activation and will lead to the elucidation of the importance of HIF-1 in different Ang II-related cell responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Addition of iron or ascorbate to such cells downregulates HIFα in a manner that requires an active PHD system and pVHL-dependent degradation pathway, suggesting that either ascorbate, iron, or both are limiting in these conditions (Knowles et al., 2003; Page et al., 2007).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Page et al., 2007
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“HIF-1 is found in all cells, whereas HIF-1 is the oxygen-regulated subunit (Wang et al., 1995).”
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“…of the von Hippel-Lindau tumor suppressor gene. pVHL is the recognition component of a E3 ligase complex necessary for ubiquitination and subsequent proteasomedependent degradation of HIF-1 (Huang et al., 1998; Maxwell et al., 1999; Cockman et al., 2000; Ivan et al., 2001; Jaakkola et al., 2001).”
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 3×
“…of the von Hippel-Lindau tumor suppressor gene. pVHL is the recognition component of a E3 ligase complex necessary for ubiquitination and subsequent proteasomedependent degradation of HIF-1 (Huang et al., 1998; Maxwell et al., 1999; Cockman et al., 2000; Ivan et al., 2001; Jaakkola et al., 2001).”
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617 · cited 1×
“HIF-1 specifically binds hypoxic response element (HRE)-driven promoters on a number of genes that include vascular endothelial growth factor (VEGF), heme oxygenase, glucose transporter-1, and erythropoietin (Semenza et al., 1991; Semenza and Wang, 1992; Lee et al., 1997).”
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 4×
“Three different HIF prolyl-hydroxylases have been described, termed PHD1, PHD2, and PHD3 for their prolyl hydroxylase domain ( Bruick and McKnight, 2001; Epstein et al., 2001).”
InfluentialHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 2×
“…of the von Hippel-Lindau tumor suppressor gene. pVHL is the recognition component of a E3 ligase complex necessary for ubiquitination and subsequent proteasomedependent degradation of HIF-1 (Huang et al., 1998; Maxwell et al., 1999; Cockman et al., 2000; Ivan et al., 2001; Jaakkola et al., 2001).”
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000 · cited 4×
“H2O2 has been shown to be implicated in HIF-1 protein induction ( Chandel et al., 2000; Gerald et al., 2004; Brunelle et al., 2005; Bell et al., 2007; Pan et al., 2007).”
Influential
Research works printed but not linked: 4
- Feldser D., 1999, Cancer Res, 59, 3915
- Knowles H. J., 2003, Cancer Res, 63, 1764
- Lyle A. N., 2006, Physiology (Bethesda), 21, 269
- Zhang G. X., 2007, Cardiovasc. Res, 7, 6204
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Vitamins C and E: Beneficial effects from a mechanistic perspective
Traber, M. G., & Stevens, J. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.017 · Cited by 1,076
“[28] to inhibit hydroxylation of proline 402 in HIF-1α.”
BackgroundAscorbic acid: Chemistry, biology and the treatment of cancer
Du, J., Cullen, J. J., & Buettner, G. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.003 · Cited by 1,070
“All three of the HIF prolyl hydroxylases (PHD1, PHD2, and PHD3) recognize the C-terminal hydroxylation site with a higher affinity than the N-terminal hydroxylation site [75].”
BackgroundInfluentialCycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
“It has recently been shown that angiotensin II mediates this effect by increasing the levels of H 2 O 2 , which depletes intracellular stores of ascorbate, an important co-factor involved in PHD activit”
BackgroundRegulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology
Kierans, S. J., & Taylor, C. T. (2021) · The Journal of Physiology · doi:10.1113/jp280572 · Cited by 1,015
“The hydroxylation of HIF-1α by PHD and FIH dioxygenases is dependent on the availability of both O2 and co-factors 2-oxoglutarate, Fe (II) and ascorbate (Knowles et al. 2003; Page et al. 2008).”
Background
Metadata
- Authors
- Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E.
- Affiliations
- Hôtel-Dieu de Québec (CA)
- Stanford Medicine (US)
- National Institutes of Health (US)
- Venue
- Molecular Biology of the Cell
- Published
- 2008-01
- Volume
- 19
- Issue
- 1
- Pages
- 86-94
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2174200
- OpenAlex
- W2003542984
- Cited by
- 181
- References
- 63
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 4 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 5 · 2014: 13 · 2013: 15 · 2012: 10
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor-1α, HIF-1α stabilization, angiotensin II, HIF prolyl hydroxylase, protein hydroxylation, ubiquitination, von Hippel-Lindau protein, hydrogen peroxide, ascorbate depletion, oxidative stress, vascular smooth muscle cells, thrombin, G protein-coupled receptor signaling
- MeSH terms
- Angiotensin II, Animals, Ascorbic Acid, Coenzymes, Half-Life, Humans, Hydrogen Peroxide, Hydroxylation, Male, Oxidation-Reduction, Procollagen-Proline Dioxygenase, Protein Binding, Protein Processing, Post-Translational, Thermodynamics, Cell Hypoxia, Rats, Wistar, Protein Structure, Tertiary, Intracellular Space, Rats, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion. https://app.cochat.ai/papers/10.1091/mbc.e07-06-0612
- The paper
- Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008). Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e07-06-0612
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.